{"id":"W2164281047","doi":"10.3109/15412555.2014.991864","title":"One-Year Safety of Olodaterol Once Daily via Respimat® in Patients with GOLD 2–4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis","year":2015,"lang":"en","type":"article","venue":"COPD Journal of Chronic Obstructive Pulmonary Disease","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada); McGill University Health Centre","funders":"Asthma and Lung UK; GlaxoSmithKline","keywords":"Medicine; Placebo; COPD; Formoterol; Adverse effect; MedDRA; Concomitant; Anesthesia; Obstructive lung disease; Internal medicine; Asthma; Pharmacovigilance; Budesonide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0169093,0.002053096,0.007984134,0.001513061,0.0002707395,0.001861788,0.000769565,0.001451233,0.001517632],"category_scores_gemma":[0.01149337,0.0007773904,0.02263496,0.001470311,0.0004315809,0.001193503,0.0009911011,0.001396705,0.0003126087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007739714,"about_ca_system_score_gemma":0.0007743834,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007114493,"about_ca_topic_score_gemma":0.001188996,"domain_scores_codex":[0.9917862,0.004055161,0.001521056,0.00117443,0.001159744,0.0003034159],"domain_scores_gemma":[0.9891589,0.00455511,0.003405432,0.001008243,0.001542309,0.0003298498],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.3124838,0.0006023709,0.04856946,0.01624865,0.5780908,0.0002159094,0.0001915064,0.00239521,0.004490456,0.0001105668,0.001291846,0.03530945],"study_design_scores_gemma":[0.05318531,0.03859323,0.2233404,0.001047292,0.6749993,0.0004175094,0.0001492481,0.00216871,0.002280911,0.0003118799,0.003334819,0.0001713913],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7872639,0.1880516,0.007342137,0.0003340777,0.0004442413,0.002017821,0.01132177,0.000291308,0.002933291],"genre_scores_gemma":[0.9713383,0.01600491,0.001783429,0.0004632488,0.0003590322,0.001103482,0.007908636,0.00005596404,0.0009829852],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0169093,"threshold_uncertainty_score":0.08942598,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01512004694865669,"score_gpt":0.2666584233690266,"score_spread":0.2515383764203699,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}